These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 11698130

  • 1. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.
    Miller CB, Rowlings PA, Zhang MJ, Jones RJ, Piantadosi S, Keating A, Armitage JO, Calderwood S, Harris RE, Klein JP, Lazarus HM, Linker CA, Sobocinski KA, Weisdorf D, Horowitz MM.
    Exp Hematol; 2001 Nov; 29(11):1336-46. PubMed ID: 11698130
    [Abstract] [Full Text] [Related]

  • 2. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging for acute myeloid leukaemia beyond first remission: a 10-year experience.
    Smith BD, Jones RJ, Lee SM, Piantadosi S, Vala MS, Fuller D, Gore SD, Noga SJ, O'Donnell PV, Braine H, Vogelsang GB, Fuchs EJ, Flinn IW, Brodsky RA, Ambinder RF, Miller CB.
    Br J Haematol; 2002 Jun; 117(4):907-13. PubMed ID: 12060130
    [Abstract] [Full Text] [Related]

  • 3. Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.
    Demirer T, Gooley T, Buckner CD, Petersen FB, Lilleby K, Rowley S, Sanders J, Storb R, Appelbaum FR, Bensinger WI.
    Bone Marrow Transplant; 1995 Jun; 15(6):907-13. PubMed ID: 7581090
    [Abstract] [Full Text] [Related]

  • 4. Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institution.
    Gorin NC, Labopin M, Laporte JP, Douay L, Lopez M, Lesage S, Fouillard L, Isnard F, Jouet JP, Bellal N, Perot C, Van Den Akker J, Bauters F, Najman A.
    Exp Hematol; 1999 Dec; 27(12):1822-30. PubMed ID: 10641600
    [Abstract] [Full Text] [Related]

  • 5. Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for children with acute non-lymphoblastic leukemia in second remission.
    Lenarsky C, Weinberg K, Petersen J, Nolta J, Brooks J, Annett G, Kohn D, Parkman R.
    Bone Marrow Transplant; 1990 Dec; 6(6):425-9. PubMed ID: 2097012
    [Abstract] [Full Text] [Related]

  • 6. Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report.
    Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL.
    Bone Marrow Transplant; 1998 Nov; 22(9):865-72. PubMed ID: 9827814
    [Abstract] [Full Text] [Related]

  • 7. Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia.
    Demirer T, Petersen FB, Bensinger WI, Appelbaum FR, Fefer A, Rowley S, Sanders J, Chauncey T, Storb R, Lilleby K, Buckner CD.
    Bone Marrow Transplant; 1996 Jul; 18(1):29-34. PubMed ID: 8831992
    [Abstract] [Full Text] [Related]

  • 8. 4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia.
    Rizzieri DA, Talbot JT, Long GD, Vredenburgh JJ, Gasparetto C, Smith CS, Colvin MO, Adams D, Morris A, Dodge R, Loftis J, Waters-Pick B, Reese M, Carawan H, Koh LP, Chao NJ.
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):183-8. PubMed ID: 12652469
    [Abstract] [Full Text] [Related]

  • 9. Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells. Laboratory and clinical observations.
    Yeager AM, Rowley SD, Kaizer H, Santos GW.
    Am J Pediatr Hematol Oncol; 1990 Mar; 12(3):245-56. PubMed ID: 2240470
    [Abstract] [Full Text] [Related]

  • 10. Randomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia.
    Dusenbery KE, Daniels KA, McClure JS, McGlave PB, Ramsay NK, Blazar BR, Neglia JP, Kersey JH, Woods WG.
    Int J Radiat Oncol Biol Phys; 1995 Jan 01; 31(1):119-28. PubMed ID: 7995742
    [Abstract] [Full Text] [Related]

  • 11. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
    Demirer T, Buckner CD, Appelbaum FR, Petersen FB, Rowley S, Weaver CH, Lilleby K, Sanders J, Chauncey T, Storb R.
    Bone Marrow Transplant; 1995 Jun 01; 15(6):915-22. PubMed ID: 7581091
    [Abstract] [Full Text] [Related]

  • 12. Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
    Damon LE, Rugo HS, Ries CA, Linker CA.
    Bone Marrow Transplant; 1996 Jan 01; 17(1):93-9. PubMed ID: 8673063
    [Abstract] [Full Text] [Related]

  • 13. Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome.
    Woolfrey AE, Gooley TA, Sievers EL, Milner LA, Andrews RG, Walters M, Hoffmeister P, Hansen JA, Anasetti C, Bryant E, Appelbaum FR, Sanders JE.
    Blood; 1998 Nov 15; 92(10):3546-56. PubMed ID: 9808546
    [Abstract] [Full Text] [Related]

  • 14. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
    Gorin NC, Labopin M, Fouillard L, Meloni G, Frassoni F, Iriondo A, Brunet Mauri S, Goldstone AH, Harousseau JL, Reiffers J, Esperou-Bourdeau H, Gluckman E.
    Bone Marrow Transplant; 1996 Jul 15; 18(1):111-7. PubMed ID: 8832003
    [Abstract] [Full Text] [Related]

  • 15. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.
    Mehta J, Powles R, Singhal S, Horton C, Tait D, Treleaven J.
    Bone Marrow Transplant; 1996 Jul 15; 18(1):119-23. PubMed ID: 8832004
    [Abstract] [Full Text] [Related]

  • 16. Use of recombinant human granulocyte-macrophage colony-stimulating factor in patients with lymphoid malignancies transplanted with unpurged or adjusted-dose mafosfamide-purged autologous marrow.
    Carlo-Stella C, Mangoni L, Almici C, Cottafavi L, Meloni G, Mandelli F, Rizzoli V.
    Blood; 1992 Nov 01; 80(9):2412-8. PubMed ID: 1421413
    [Abstract] [Full Text] [Related]

  • 17. Autologous blood cell vs marrow transplantation for acute myeloid leukemia in complete remission: an EBMT retrospective analysis.
    Reiffers J, Labopin M, Sanz M, Korbling M, Blaise D, De La Rubia J, Gorin NC.
    Bone Marrow Transplant; 2000 Jun 01; 25(11):1115-9. PubMed ID: 10849522
    [Abstract] [Full Text] [Related]

  • 18. Purging with 4-hydroperoxycyclophosphamide.
    Jones RJ.
    J Hematother; 1992 Jun 01; 1(4):343-8. PubMed ID: 1345676
    [Abstract] [Full Text] [Related]

  • 19. Autologous bone marrow transplantation for acute myeloid leukemia in remission or first relapse using monoclonal antibody-purged marrow: results of phase II studies with long-term follow-up.
    Ball ED, Wilson J, Phelps V, Neudorf S.
    Bone Marrow Transplant; 2000 Apr 01; 25(8):823-9. PubMed ID: 10808202
    [Abstract] [Full Text] [Related]

  • 20. Autologous bone marrow transplantation in acute myeloid leukemia: the University of Minnesota experience.
    Dusenbery KE, Steinbuch M, McGlave PB, Ramsay NK, Blazar BR, Neglia JP, Litz C, Kersey JH, Woods WG.
    Int J Radiat Oncol Biol Phys; 1996 Sep 01; 36(2):335-43. PubMed ID: 8892457
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.